Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to KURA. [ FAQ on what and how to ask] For non-KURA questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 4930 Directors Place, Suite 500, San Diego, CA, United States, 92121
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Chairman, CEO & President
Chief Operating Officer
Chief Commercial Officer
Chief Financial Officer
Senior Vice President of Finance & Accounting
Chief Scientific Officer
Senior Vice President of Investor Relations & Corporate Affairs
Chief Legal Officer & Corporate Secretary
Senior Vice President of Manufacturing & Supply Chain
Chief Medical Officer
My Watchlist
